US20090186145A1 - Composition for Preventing and Improving Metabolic Syndrome - Google Patents
Composition for Preventing and Improving Metabolic Syndrome Download PDFInfo
- Publication number
- US20090186145A1 US20090186145A1 US12/227,951 US22795107A US2009186145A1 US 20090186145 A1 US20090186145 A1 US 20090186145A1 US 22795107 A US22795107 A US 22795107A US 2009186145 A1 US2009186145 A1 US 2009186145A1
- Authority
- US
- United States
- Prior art keywords
- protein
- soybean
- soybean germ
- composition according
- germ protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 43
- 208000001145 Metabolic Syndrome Diseases 0.000 title claims abstract description 8
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title claims abstract description 8
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 126
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 124
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 124
- 244000068988 Glycine max Species 0.000 claims abstract description 122
- 239000008280 blood Substances 0.000 claims abstract description 51
- 210000004369 blood Anatomy 0.000 claims abstract description 51
- 230000001603 reducing effect Effects 0.000 claims abstract description 17
- 238000008214 LDL Cholesterol Methods 0.000 claims abstract description 15
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000037396 body weight Effects 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 210000004185 liver Anatomy 0.000 claims abstract description 7
- 235000005911 diet Nutrition 0.000 claims description 45
- 230000037213 diet Effects 0.000 claims description 45
- 238000011282 treatment Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 22
- 235000013305 food Nutrition 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 9
- 235000013376 functional food Nutrition 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 4
- 230000037356 lipid metabolism Effects 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 42
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 3
- 239000008103 glucose Substances 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 113
- 108010073771 Soybean Proteins Proteins 0.000 description 23
- 235000019710 soybean protein Nutrition 0.000 description 23
- 238000012360 testing method Methods 0.000 description 19
- 102000011632 Caseins Human genes 0.000 description 16
- 108010076119 Caseins Proteins 0.000 description 16
- 239000005018 casein Substances 0.000 description 16
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 16
- 235000021240 caseins Nutrition 0.000 description 16
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 15
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 15
- 235000008696 isoflavones Nutrition 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 12
- 229930182490 saponin Natural products 0.000 description 12
- 150000007949 saponins Chemical class 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 241000700159 Rattus Species 0.000 description 10
- 239000003925 fat Substances 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 9
- 235000019197 fats Nutrition 0.000 description 9
- -1 glycerin fatty acid ester Chemical class 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 230000035508 accumulation Effects 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 235000004458 antinutrient Nutrition 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 235000019486 Sunflower oil Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000013566 allergen Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000014510 cooky Nutrition 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000002600 sunflower oil Substances 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000001596 intra-abdominal fat Anatomy 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 230000031787 nutrient reservoir activity Effects 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- CDDWAYFUFNQLRZ-KJVHGCRFSA-N (3beta,21beta,22beta)-olean-12-ene-3,21,22,24-tetrol Chemical compound C([C@@]12C)C[C@H](O)[C@](C)(CO)[C@@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)[C@@H](O)[C@@H](O)[C@]3(C)CC[C@]21C CDDWAYFUFNQLRZ-KJVHGCRFSA-N 0.000 description 1
- YOQAQNKGFOLRGT-UXXABWCISA-N (3beta,22beta)-olean-12-ene-3,22,24-triol Chemical compound C1C[C@H](O)[C@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)[C@H](O)CC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C YOQAQNKGFOLRGT-UXXABWCISA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101710102211 11S globulin Proteins 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101000767750 Carya illinoinensis Vicilin Car i 2.0101 Proteins 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 101000767759 Corylus avellana Vicilin Cor a 11.0101 Proteins 0.000 description 1
- 101710190853 Cruciferin Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 244000058871 Echinochloa crus-galli Species 0.000 description 1
- 235000008247 Echinochloa frumentacea Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 101000622316 Juglans regia Vicilin Jug r 2.0101 Proteins 0.000 description 1
- URRZRRQMNMZIAP-UHFFFAOYSA-N Kudzusapogenol C Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)CC3(C)CCC21C URRZRRQMNMZIAP-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 101000767757 Pinus koraiensis Vicilin Pin k 2.0101 Proteins 0.000 description 1
- 101000767758 Pistacia vera Vicilin Pis v 3.0101 Proteins 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940048879 dl tartaric acid Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 101150073877 egg-1 gene Proteins 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 108010083391 glycinin Proteins 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 230000006372 lipid accumulation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 108700005457 microfibrillar Proteins 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008171 pumpkin seed oil Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940107524 soy germ Drugs 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- CDDWAYFUFNQLRZ-UHFFFAOYSA-N soyasapogenol A Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)C(O)C(O)C3(C)CCC21C CDDWAYFUFNQLRZ-UHFFFAOYSA-N 0.000 description 1
- MADZMXIFUWFDJK-AEARDBQCSA-N soyasapogenol B Natural products CC1(C)C[C@@H](O)[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@H]2C1 MADZMXIFUWFDJK-AEARDBQCSA-N 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 235000019587 texture Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
- A21D2/266—Vegetable proteins from leguminous or other vegetable seeds; from press-cake or oil bearing seeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a composition for preventing and improving metabolic syndrome utilizing soy germ protein, more specifically to a composition for improving the blood lipid condition and the blood sugar level, controlling the increase in liver weight, and reducing the body weight.
- soybeans have been eaten in various forms, such as bean curd, soybean milk, deep-fat fried bean curd, boiled beans, fermented soybeans, soybean flour, miso (fermented soybean paste), and soy sauce.
- Soybean protein defatted soybean
- soybean protein is called “field meat”, and widely used for food and feed applications.
- Functional components contained in soybeans, such as isoflavone, lecithin, and vitamin E are also receiving attention, and these useful components have been used as supplements for, for example, prevention of various diseases.
- soybeans also contains a trypsin inhibitor which inhibits the activity of proteolytic enzymes, an antigenic protein as an allergen which causes an allergy, phytic acid which inhibits absorption of minerals and the like. Effective use of soybean as a nutritional functional food is based on two main points of efficient use of useful components and reduction of antinutrient components.
- soybeans reduce the blood cholesterol level. The effect is likely due to that soybean protein specifically binds to cholesterol precursors such as bile acid, and is excreted as feces.
- Patent Document 1 Non-patent Documents 1 and 2.
- Patent Document 2 As other soybean components which improve the blood neutral lipid, cholesterol and blood sugar levels, 11S globulin called glycinin (Patent Document 2), 7S globulin called ⁇ -conglycinin, isoflavone, and others are said to be effective, but no clear conclusion has been provided. Further, proteins of soybean germ have little been studied.
- isoflavone aglycon which is contained in a substance prepared by treating soybean germ with aspergillus oryzae , hydrolyzing the product, and extracting and concentrating the product with a solvent, is effective as an active ingredient for promoting bioactivity (Patent Document 3).
- Patent Document 3 there still are different opinions among researchers about the efficacy of isoflavone inclusive of its metabolites, so that no clear conclusion has been provided.
- soybean germ The protein composition of soybean germ is markedly different from that of soybean. Soybean germ has a low nutritional value because it contains little storage protein such as conglycinin and ⁇ -conglycinin, and its total protein content is low. In addition, soybean germ abundantly contains antinutrients such as saponin and allergens, so that its excessive ingestion causes an allergy, growth inhibition or the like. Soybean germ further has a bad flavor. Therefore, it is believed to be unsuitable for uses in foods, beverages, and medicines. The inventors have applied for a patent on a soybean germ protein composition which resolves the problem (Japanese Patent Application No. 2005-36942). The composition is prepared by removing antinutrient components from soybean germ through solvent treatment in combination with heat treatment.
- the process increases the content of soybean germ protein while decreasing the content of allergens derived from the protein, and improves the flavor.
- functionality of soybean germ protein, more specifically, processing characteristics and physiological effects caused by the ingestion of the protein have not known at all until the completion of the present invention.
- the present invention is intended to identify a functional component of soybean having the effect of improving the blood lipid and blood sugar levels, which has not been revealed, and utilize the component in food, beverages, drugs or a material thereof.
- An aspect of the present invention is a composition for improving blood lipid level and blood sugar level, an active ingredient of the composition being a fraction containing soybean germ protein obtained through fractionation carried out such that the fraction contains germ protein, which is a minor element of soybeans, at a ratio of 20% or more, more preferably 40% or more.
- germ protein which is a minor element of soybeans
- an active ingredient of the composition being a fraction containing soybean germ protein obtained through fractionation carried out such that the fraction contains germ protein, which is a minor element of soybeans, at a ratio of 20% or more, more preferably 40% or more.
- the present invention is directed to a composition for improving blood HDL/LDL cholesterol ratio, reducing blood triglyceride level, reducing blood sugar level, and reducing body weight, the composition containing soybean germ protein as an active ingredient.
- composition according to the present invention improves blood cholesterol level, triglyceride and blood sugar level, thereby contributing to health promotion.
- FIG. 1 is a view showing electrophoretic patterns of proteins.
- FIG. 2 is a view showing electrophoretic patterns of defatted proteins.
- FIG. 3 is a view showing electrophoretic patterns of a concentrated soybean germ protein.
- FIG. 4 is a graph showing the change in total blood cholesterol concentration after administration of germ protein and SPC.
- FIG. 5 is a graph showing the change in blood LDL cholesterol concentration after administration of germ protein and SPC.
- FIG. 6 is a graph showing the change in blood HDL cholesterol concentration after administration of germ protein and SPC.
- FIG. 7 is a graph showing the change in blood HDL cholesterol/blood LDL cholesterol ratio after administration of germ protein and SPC.
- FIG. 8 is a graph showing the change in blood triglyceride concentration after administration of germ protein and SPC.
- FIG. 9 is a graph showing the change in blood sugar level after administration of germ protein and SPC.
- FIG. 10 is a graph showing the change in liver weight per body weight after administration of germ protein and SPC.
- FIG. 11 is a graph showing the change in total blood cholesterol concentration after administration of germ protein and SPC.
- soybean germ protein Common soybean contains about 0.8% soybean germ protein, though the content varies among species. Isolation of soybean germ protein from soybean may employ any method. For example, soybean may be half-crushed, and sieved to obtain soybean germ. Under the method, the soybean germ protein is concentrated to about 50-fold. The concentrate may be further defatted thereby removing the lipid component to increase the concentration of the soybean germ protein. Alternatively, the protein may be extracted with water or any organic solvent, preferably hydrous alcohol at 0° C. to 100° C. When the extracted soybean germ protein is heated at 50 to 300° C. for 1 to 180 minutes, soybean germ protein having an excellent flavor and a high nutritional value is obtained. If the heat treatment is carried out at a temperature lower than 50° C.
- the solvent treatment and heat treatment may be performed sequentially or simultaneously, or either one treatment may be dispensed with. They may be combined with other treatment processes such as pulverization, separation, and chromatography.
- the soybean germ protein of the present invention may be produced from common soybean protein such as defatted soybean, soybean protein concentrate, soybean protein isolate, and soybean milk through removal of storage protein specifically abundant in the cotyledon of soybean, and fibers abundant in seed coat.
- the germ portion of soybean contains isoflavone and saponin at relatively high concentrations, so that excess intake of the germ needs to be careful of.
- combination of the above methods provides soybean germ protein which contains less isoflavone and saponin, and can safely be taken.
- soybean germ when soybean germ is subjected to solvent treatment with hexane and/or hydrous alcohol, and heat treatment at 50 to 300° C. for 1 to 80 minutes, the isoflavone content is decreased to 0.5% or less, and the saponin content is decreased to 1% or less. More specifically, when soybean germ is subjected to solvent treatment with 70% ethanol at 70° C. for 30 minutes, and heat treatment at 100° C. for 40 minutes, the isoflavone content is decreased to about 0.1%, and the saponin content is decreased to about 0.2%.
- soybean germ protein is markedly different from the protein composition of ordinary soybean, and thus can be readily identified by SDS-PAGE analysis.
- the soybean germ protein obtained according to the present invention has the following effects.
- the soybean germ protein of the present invention is superior to casein and soybean protein in the effects of reducing the blood LDL cholesterol and increasing the blood HDL cholesterol, and in the effect of improving the blood HDL/LDL cholesterol ratio.
- the soybean germ protein prevents fat accumulation in organs thereby preventing metabolic syndrome. The effects are intrinsic to the soybean germ protein and are not found in soybean protein concentrate.
- the soybean germ protein of the present invention has the effect of reducing the blood triglyceride.
- the soybean germ protein of the present invention has the effect of reducing the blood sugar level.
- the soybean germ protein of the present invention has the effect of suppressing accumulation of body fat such as visceral fat, and reducing the body weight.
- the content of germ protein is so low that the above-described effects achieved by the present invention cannot be obtained.
- physiological action can be provided by increasing the concentration of the germ protein according to the present invention. More specifically, the effects are achieved by an ingestion of about 0.05 g to 50 g of the soybean germ protein of the present invention per day, so that the protein can be added to various food or beverages.
- soybean germ protein according to the present invention may be used alone as an active ingredient, or in the form of, for example, a solid, liquid, sol, gel, or plastic composition containing a cereal powder such as starch, oils and fats, emulsifying agent, fragrant material, or thickener according to the requirements of the end product (e.g., drug, functional food, dietary supplement, food, or drink).
- a cereal powder such as starch, oils and fats, emulsifying agent, fragrant material, or thickener according to the requirements of the end product (e.g., drug, functional food, dietary supplement, food, or drink).
- starch examples include corn starch, waxy corn starch, high amylose corn starch, potato starch, wheat starch, tapioca starch, green bean starch, sago starch, rice starch, pea starch, and processed products of these starches prepared by subjecting a starch to single or combined physical or chemical treatment such as esterification treatment, etherification treatment, crosslinking treatment, acid treatment, oxidation treatment, heat-moisture treatment, and gelatinization treatment.
- physical or chemical treatment such as esterification treatment, etherification treatment, crosslinking treatment, acid treatment, oxidation treatment, heat-moisture treatment, and gelatinization treatment.
- oils and fats examples include soy oil, soybean germ oil, rapeseed oil, high oleic rapeseed oil, corn oil, sesame oil, sesame salad oil, perilla oil, linseed oil, peanut oil, safflower oil, high oleic safflower oil, sunflower oil, high oleic sunflower oil, high linolic sunflower oil, mid oleic sunflower oil, cottonseed oil, grape seed oil, macadamia nut oil, hazelnut oil, walnut oil, pumpkin seed oil, camellia oil, tea seed oil, olive oil, rice bran oil, wheat germ oil, palm oil, palm olein, palm kernel oil, coconut oil, cacao butter, algae oil, and hydrogenated oil, interesterified oil, and fractionated oil of these oils. These oils may be used alone or in combination of two or more of them.
- the emulsifying agent may be one commonly used for food.
- the emulsifying agent include glycerin fatty acid ester, glycerin organic acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, polyglycerin fatty acid ester, polyglycerin-condensed ricinolate, sucrose fatty acid ester, calcium stearoyl lactate, alkyl glycosides, erythritol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, lecithin, enzymatically decomposed lecithin, and enzymatically modified lecithin.
- These emulsifying agents may be used alone or in combination of two or more of them.
- the fragrant material may be a natural or synthetic fragrant material commonly used in foods.
- the thickener increases the viscosity of the aqueous solution, and examples thereof include polysaccharides such as gum arabic, arabino galactan, guar gum, xanthan gum, psyllium seed gum, gellan gum, Tara gum, locust bean gum, tamarind seed gum, water-soluble soy polysaccharide (hemicellulose), sodium alginate, pullulan, pectin, karaya gum, ghatti gum, gum tragacanth, curdlan, glucomannan, chitin, chitosan, microfibrillar cellulose, and microcrystalline cellulose.
- polysaccharides such as gum arabic, arabino galactan, guar gum, xanthan gum, psyllium seed gum, gellan gum, Tara gum, locust bean gum, tamarind seed gum, water-soluble soy polysaccharide (hemicellulose), sodium alginate, pullulan, pectin, karaya
- additives examples include protein-derived substances such as collagen peptide, lactoprotein peptide, casein peptide, oligopeptide, whey protein concentrate, pea protein and gelatin, fibers such as soy fiber and pea fiber, and dextrin such as highly branched cyclic dextrin.
- a pH adjuster and a saccharide may be added to the soybean germ protein.
- pH adjuster examples include lactic acid, gluconic acid, succinic acid, fumaric acid, citric acid, L-malic acid, DL-malic acid, glacial acetic acid, glucono delta lactone, L-tartaric acid, and DL-tartaric acid.
- saccharide examples include glucose (grape sugar), maltose, fructose (fruit sugar), galactose, trehalose, oligosaccharide, sucrose, and sorbit.
- the soybean germ protein of the present invention When the soybean germ protein of the present invention is contained in a baked confectionery such as cookie with a content of 1 to 50%, the baked confectionery has crispness which cannot be achieved with a common soybean protein, and gives a good smell and a good flavor.
- the soybean germ protein of the present invention complements the flavor of food when it is mixed with a grain such as barley, wheat, rice, Japanese millet, foxtail millet, brown rice, black bean, red rice, green rice, red bean, black bean, red kidney bean, chickpea, white kidney bean, or the germ portion of these beans, or a seed such as peanut, walnut, sesame, pine nut, or chestnut.
- a grain such as barley, wheat, rice, Japanese millet, foxtail millet, brown rice, black bean, red rice, green rice, red bean, black bean, red kidney bean, chickpea, white kidney bean, or the germ portion of these beans, or a seed such as peanut, walnut, sesame, pine nut, or chestnut.
- the soybean germ protein is suitable for, for example, cereals, baked confectionery, and energy bars owing to its physiological functionality.
- Soybeans were mechanically crushed, and sieved to obtain a concentrated fraction of soybean germ protein containing 70% or more of soybean germ.
- the concentrated fraction obtained by the method was subjected to total nitrogen analysis, and confirmed to have a total protein content of 40%.
- 70% or more of the protein was derived from soybean germ, so that the content of the soybean germ protein in the product was 28% or more, and the concentration factor was 35-fold or more.
- the protein composition of the sample was analyzed by SDS-PAGE.
- the sample was mixed with 20 ⁇ l of a 10% glycerol solution containing 1% bromophenol blue, and subjected to boiling treatment for 5 minutes in a boiling water bath to obtain a sample for electrophoresis.
- the addition of ⁇ -mercaptoethanol is an important step, because the electrophoretic patterns markedly differ according to whether ⁇ -mercaptoethanol is added or not.
- Electrophoresis was carried out using PhastSystem (Pharmacia LKB Biotechnology).
- the electrophoresis gel was PhastGel, Gradient 10-15, and staining was carried out with CBB.
- the stained polypeptide bands isolated by SDS-PAGE were analyzed with a chromatoscanner CS9300 (manufactured by Shimadzu Corporation) thereby measuring the absorption at 560 nm.
- Ordinary soybeans show a strong band in the vicinity of 33 kD, while the soybean germ protein shows a strong band in the vicinity of 30 kD.
- ordinary soybeans show a strong band in the vicinity of 48 kD
- soybean germ protein shows a characteristic strong band in the vicinity of 52 kD
- the image was graphed by the chromatoscanner, and the peak areas in the graph indicated that the bands of the soybean germ protein were stronger than those of the ordinary soybean protein.
- the electrophoretic patterns of the proteins are shown in FIG. 1 .
- Soybeans were mechanically crushed, and sieved to obtain a fraction containing 70% or more of soybean germ.
- the fraction was defatted through hexane extraction at low and high temperatures, which is a common procedure for an oil pressing process, to obtain a soybean germ protein fraction.
- the soybean germ protein obtained by the above method was subjected to total nitrogen analysis, and found to have a total protein content of 43%, a soybean germ protein content of 30% or more, and a concentration factor of 37-fold or more.
- the protein composition of the sample was analyzed by SDS-PAGE.
- Electrophoresis was carried out using PhastSystem (Pharmacia LKB Biotechnology).
- the electrophoresis gel was PhastGel, Gradient 10-15, and staining was carried out with CBB.
- the stained polypeptide bands isolated by SDS-PAGE were analyzed with a chromatoscanner CS9300 (manufactured by Shimadzu Corporation) thereby measuring the absorption at 560 nm.
- Ordinary soybeans show a strong band in the vicinity of 33 kD, while the soybean germ protein shows a strong band in the vicinity of 30 kD.
- ordinary soybeans show a strong band in the vicinity of 48 kD
- soybean germ protein shows a characteristic strong band in the vicinity of 52 kD
- the image was graphed by the chromatoscanner, and the peak areas in the graph indicated that the bands of the soybean germ protein were stronger than those of the ordinary soybean protein.
- the electrophoretic patterns of the defatted proteins are shown in FIG. 2 .
- Soybeans were mechanically crushed, and sieved to obtain a fraction containing 90% or more of soybean germ.
- the fraction was subjected to hexane extraction in a common procedure for an oil pressing process. Subsequently, 70% hydrous ethanol was added to the fraction, the mixture was stirred at 70° C. for 30 minutes, and then filtered to collect the residue. The residue was subjected to heat treatment at 100° C. for 40 minutes under reduced pressure to obtain a soybean germ protein fraction.
- the soybean germ protein obtained by the method was subjected to total nitrogen analysis, and found to have a total protein content of 62%, a soybean germ protein content of 56% or more, and a concentration factor of 70-fold or more.
- the sample was analyzed by SDS-PAGE in the same manner as Test Example 1, and found to have a characteristic composition of soybean germ protein in which the band in the vicinity of 30 kD was stronger than that in the vicinity of 33 kD, the band in the vicinity of 52 kD was stronger than that in the vicinity of 48 kD, and other bands were shown in the vicinity of 21 kD and 35 kD.
- FIG. 3 shows an electrophoretic pattern of the concentrated soybean germ protein.
- the isoflavone and saponin contents in the soybean germ proteins obtained in Test Examples 1 to 3 were measured.
- Isoflavone content was analyzed according to a method based on the soy isoflavone food standard established by Japan Health Food & Nutrition Food Association, and the isoflavone content was determined in terms of aglycon.
- the saponin content was analyzed by the following method.
- a sample containing about 10 mg of soy saponin was weighed, and refluxed at 80° C. for 2 hours in 5 ml of a 10% hydrogen chloride-methanol test solution. Insoluble matter was removed from the solution by centrifugation and filtration, and then the solution was analyzed by HPLC.
- HPLC used ODS columns, and the absorption at UV 210 nm was measured under the conditions of
- High fat diets were fed to rats.
- concentrations of various physiological substances in the blood were compared among rats fed with casein, with soybean protein concentrate (hereinafter abbreviated as SPC) as other common soybean protein or with the soybean germ protein of Test Example 3 (hereinafter abbreviated as germ protein).
- SPC soybean protein concentrate
- germ protein soybean germ protein of Test Example 3
- the germ protein was in the form of powder.
- CD CD (SD) IGS male rats aged nine weeks were placed in individual cages, and preliminarily bred with a purified diet (AIN93G) for one week. Before starting the main test, the rats were grouped into three divisions each containing eight rats such that the divisions have an equal average body weight. The rats of the respective divisions were fed with 1. casein diet (control), 2. SPC diet containing SPC in place of casein, or 3. germ protein diet containing germ protein in place of casein. The test period was 28 days, and water and the diets were freely ingested. The test was carried out in an animal room under the following conditions: temperature, 22 ⁇ 3° C.; humidity, 60 ⁇ 15%; frequency of ventilation, 12 to 15 times/hour; and photoperiod, 12 hours (7 to 19 o'clock).
- the rats were fasted for 18 hours from the evening of the last day of administration, and the blood was collected from the aorta abdominal is under ether anesthesia.
- the blood was taken in blood-collecting vessels containing a serum separating medium, and the vessels were centrifuged at 3000 rpm for 15 minutes to separate the serum.
- the serum was assayed for the levels of LDL cholesterol ( FIG. 4 ), HDL cholesterol ( FIG. 5 ), triglyceride ( FIG. 7 ), and blood sugar level ( FIG. 8 ). Further, the HDL cholesterol/LDL cholesterol ratio was calculated from the LDL cholesterol and HDL cholesterol levels ( FIG. 6 ). After blood collection, the rats were exsanguinated to death, their livers were harvested and weighed.
- mesenteric fat, retroperitoneal fat, perinephric fat and epididymal fat were isolated from the rats of the casein diet group and germ protein diet group to study the accumulation of fats.
- the measurement values were expressed by average ⁇ standard deviation. In the statistical analysis, Tukey multiple comparison test was carried out as necessary, and the significant differences between the measurement values were examined.
- FIGS. 1 to 11 indicate the followings.
- FIG. 4 indicates that the germ protein diet decreases the total blood cholesterol.
- FIG. 5 indicates that the germ protein diet decreases the blood LDL cholesterol.
- FIG. 6 indicates that the germ protein diet increases the blood HDL cholesterol.
- FIG. 7 indicates that the germ protein diet increases the blood HDL/LDL cholesterol ratio more than the casein diet, and that the germ protein diet significantly increased the HDL/LDL ratio in comparison with the SPC diet (P ⁇ 0.05). The germ protein diet also significantly increased the cholesterol ratio in terms of HDL/total cholesterol in comparison with the SPC diet.
- FIG. 8 indicates that the SPC and germ protein diets significantly decreased the blood triglyceride in comparison with the casein diet (P ⁇ 0.05).
- FIG. 9 indicates that the SPC and germ protein diets significantly decreased the blood sugar level in comparison with the casein diet (P ⁇ 0.01 and P ⁇ 0.05 for the SPC and germ protein diets, respectively).
- FIG. 10 indicates that only the germ protein diet significantly decreased the liver weight per body weight in comparison with the casein diet (P ⁇ 0.05), which demonstrates that the germ protein diet is effective in prevention of fatty liver.
- FIG. 11 indicates that the accumulation of the mesenteric fat, retroperitoneal fat, perinephric fat and epididymal fat was smaller in weight in the division fed with the germ protein diet than the division fed with the casein diet, which shows that the germ protein diet suppresses accumulation of fats.
- the germ protein diet decreased the blood triglyceride and blood sugar level in comparison with the casein diet.
- the germ protein diet improved the HDL/LDL cholesterol ratio and HDL/total cholesterol ratio in comparison with SPC, showing that it prevents lipid accumulation in the liver. Accordingly, it was proved that the germ protein of the present invention has physiological function different from that of ordinary soybean protein.
- the dough was preserved at 4° C. for 2 hours, shaped into disks having a diameter of about 3 cm, and baked in an oven at 170° C. for about 12 minutes to make cookies.
- the cookies were tasted, and evaluated by sensory test by ten panelists. As a result of the sensory test, the cookies made of the soybean germ protein were more fragrant and crisp than those made of the separated soybean protein, and thus achieved higher scores in terms of flavor, texture, and taste.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The present invention is intended to provide a composition for preventing or improving metabolic syndrome, which is safe and efficiently ingestible. Provided is a composition for reducing blood cholesterol level, improving blood HDL/LDL cholesterol ratio, reducing blood triglyceride level, reducing blood sugar level, controlling increase in liver weight, and/or reducing body weight, the composition containing soybean germ protein as an active ingredient. The composition according to the present invention improves blood cholesterol level, triglyceride, and glucose levels thereby contributing to health promotion.
Description
- The present invention relates to a composition for preventing and improving metabolic syndrome utilizing soy germ protein, more specifically to a composition for improving the blood lipid condition and the blood sugar level, controlling the increase in liver weight, and reducing the body weight.
- In Japan, from ancient times, soybeans have been eaten in various forms, such as bean curd, soybean milk, deep-fat fried bean curd, boiled beans, fermented soybeans, soybean flour, miso (fermented soybean paste), and soy sauce. In recent years, various physiological components are receiving attention, so that soybean is expected to serve as food useful for health maintenance. Soybean protein (defatted soybean), which is prepared by removing oil from soybean, contains about 40 to 50% protein, and has relatively good amino acid balance of a vegetable protein. Therefore, soybean protein is called “field meat”, and widely used for food and feed applications. Functional components contained in soybeans, such as isoflavone, lecithin, and vitamin E are also receiving attention, and these useful components have been used as supplements for, for example, prevention of various diseases. However, soybeans also contains a trypsin inhibitor which inhibits the activity of proteolytic enzymes, an antigenic protein as an allergen which causes an allergy, phytic acid which inhibits absorption of minerals and the like. Effective use of soybean as a nutritional functional food is based on two main points of efficient use of useful components and reduction of antinutrient components.
- On the other hands, in recent years, metabolic syndrome has become a significant public health issue particularly among people of middle and advanced age, and food and drugs for improving the syndrome have been demanded. It is well known that soybeans reduce the blood cholesterol level. The effect is likely due to that soybean protein specifically binds to cholesterol precursors such as bile acid, and is excreted as feces.
- In order to investigate the physiological functions such as the cholesterol reducing effect, identification of functional fractions of peptide components obtained from decomposed soybean protein has been studied. For example, it is confirmed that undigested fractions obtained by enzymatic digestion of soybean protein lower the cholesterol level (Patent Document 1, Non-patent Documents 1 and 2). As other soybean components which improve the blood neutral lipid, cholesterol and blood sugar levels, 11S globulin called glycinin (Patent Document 2), 7S globulin called β-conglycinin, isoflavone, and others are said to be effective, but no clear conclusion has been provided. Further, proteins of soybean germ have little been studied.
- Regarding the substances derived from soybean germ, it is reported that isoflavone aglycon, which is contained in a substance prepared by treating soybean germ with aspergillus oryzae, hydrolyzing the product, and extracting and concentrating the product with a solvent, is effective as an active ingredient for promoting bioactivity (Patent Document 3). However, there still are different opinions among researchers about the efficacy of isoflavone inclusive of its metabolites, so that no clear conclusion has been provided.
- The protein composition of soybean germ is markedly different from that of soybean. Soybean germ has a low nutritional value because it contains little storage protein such as conglycinin and β-conglycinin, and its total protein content is low. In addition, soybean germ abundantly contains antinutrients such as saponin and allergens, so that its excessive ingestion causes an allergy, growth inhibition or the like. Soybean germ further has a bad flavor. Therefore, it is believed to be unsuitable for uses in foods, beverages, and medicines. The inventors have applied for a patent on a soybean germ protein composition which resolves the problem (Japanese Patent Application No. 2005-36942). The composition is prepared by removing antinutrient components from soybean germ through solvent treatment in combination with heat treatment. The process increases the content of soybean germ protein while decreasing the content of allergens derived from the protein, and improves the flavor. However, functionality of soybean germ protein, more specifically, processing characteristics and physiological effects caused by the ingestion of the protein have not known at all until the completion of the present invention.
-
- Patent Document 1: Japanese Patent Publication No. 07-025796
- Patent Document 2: Japanese Patent Application Laid-Open No. 2003-88334
- Patent Document 3: WO 2003/077904
- Non-patent Document 1: Atherosclerosis, 72, 115, 1988
- Non-patent Document 2: J. Nutr., 120, 977, 1990
- The present invention is intended to identify a functional component of soybean having the effect of improving the blood lipid and blood sugar levels, which has not been revealed, and utilize the component in food, beverages, drugs or a material thereof.
- An aspect of the present invention is a composition for improving blood lipid level and blood sugar level, an active ingredient of the composition being a fraction containing soybean germ protein obtained through fractionation carried out such that the fraction contains germ protein, which is a minor element of soybeans, at a ratio of 20% or more, more preferably 40% or more. Further, when the obtained soybean germ protein is subjected to, for example, solvent treatment, chemical treatment, or physical treatment thereby removing antinutrient components, and in combination with heat treatment, the protein content in the resultant soybean germ protein increases while the content of allergens derived from the protein decreases, and the flavor of the protein is improved.
- More specifically, the present invention is directed to a composition for improving blood HDL/LDL cholesterol ratio, reducing blood triglyceride level, reducing blood sugar level, and reducing body weight, the composition containing soybean germ protein as an active ingredient.
- The composition according to the present invention improves blood cholesterol level, triglyceride and blood sugar level, thereby contributing to health promotion.
-
FIG. 1 is a view showing electrophoretic patterns of proteins. -
FIG. 2 is a view showing electrophoretic patterns of defatted proteins. -
FIG. 3 is a view showing electrophoretic patterns of a concentrated soybean germ protein. -
FIG. 4 is a graph showing the change in total blood cholesterol concentration after administration of germ protein and SPC. -
FIG. 5 is a graph showing the change in blood LDL cholesterol concentration after administration of germ protein and SPC. -
FIG. 6 is a graph showing the change in blood HDL cholesterol concentration after administration of germ protein and SPC. -
FIG. 7 is a graph showing the change in blood HDL cholesterol/blood LDL cholesterol ratio after administration of germ protein and SPC. -
FIG. 8 is a graph showing the change in blood triglyceride concentration after administration of germ protein and SPC. -
FIG. 9 is a graph showing the change in blood sugar level after administration of germ protein and SPC. -
FIG. 10 is a graph showing the change in liver weight per body weight after administration of germ protein and SPC. -
FIG. 11 is a graph showing the change in total blood cholesterol concentration after administration of germ protein and SPC. - Common soybean contains about 0.8% soybean germ protein, though the content varies among species. Isolation of soybean germ protein from soybean may employ any method. For example, soybean may be half-crushed, and sieved to obtain soybean germ. Under the method, the soybean germ protein is concentrated to about 50-fold. The concentrate may be further defatted thereby removing the lipid component to increase the concentration of the soybean germ protein. Alternatively, the protein may be extracted with water or any organic solvent, preferably hydrous alcohol at 0° C. to 100° C. When the extracted soybean germ protein is heated at 50 to 300° C. for 1 to 180 minutes, soybean germ protein having an excellent flavor and a high nutritional value is obtained. If the heat treatment is carried out at a temperature lower than 50° C. and/or for a period of less than 1 minute, modification of the protein is insufficient, and if the temperature is higher than 300° C. and/or the period is more than 180 minutes, the protein is burned and the amino acids decrease. According to a method of removing the antinutrient components from soybean germ through extraction with an aqueous solvent and then collecting specific proteins by isoelectric precipitation under pH control with an acid or alkali, extraction and collection can be carried out with simple equipment. Alternatively, according to a method of extracting and removing low polarity substances using supercritical carbon dioxide, carbon dioxide is vaporized in a state that it is returned to normal temperature and normal pressure conditions, which advantageously dispenses with subsequent drying treatment.
- In the present invention, the solvent treatment and heat treatment may be performed sequentially or simultaneously, or either one treatment may be dispensed with. They may be combined with other treatment processes such as pulverization, separation, and chromatography. The soybean germ protein of the present invention may be produced from common soybean protein such as defatted soybean, soybean protein concentrate, soybean protein isolate, and soybean milk through removal of storage protein specifically abundant in the cotyledon of soybean, and fibers abundant in seed coat. The germ portion of soybean contains isoflavone and saponin at relatively high concentrations, so that excess intake of the germ needs to be careful of. However, combination of the above methods provides soybean germ protein which contains less isoflavone and saponin, and can safely be taken.
- For example, when soybean germ is subjected to solvent treatment with hexane and/or hydrous alcohol, and heat treatment at 50 to 300° C. for 1 to 80 minutes, the isoflavone content is decreased to 0.5% or less, and the saponin content is decreased to 1% or less. More specifically, when soybean germ is subjected to solvent treatment with 70% ethanol at 70° C. for 30 minutes, and heat treatment at 100° C. for 40 minutes, the isoflavone content is decreased to about 0.1%, and the saponin content is decreased to about 0.2%.
- The obtained soybean germ protein is markedly different from the protein composition of ordinary soybean, and thus can be readily identified by SDS-PAGE analysis.
- The soybean germ protein obtained according to the present invention has the following effects.
- Firstly, the soybean germ protein of the present invention is superior to casein and soybean protein in the effects of reducing the blood LDL cholesterol and increasing the blood HDL cholesterol, and in the effect of improving the blood HDL/LDL cholesterol ratio. In addition, the soybean germ protein prevents fat accumulation in organs thereby preventing metabolic syndrome. The effects are intrinsic to the soybean germ protein and are not found in soybean protein concentrate.
- Secondly, the soybean germ protein of the present invention has the effect of reducing the blood triglyceride.
- Thirdly, the soybean germ protein of the present invention has the effect of reducing the blood sugar level.
- Fourthly, the soybean germ protein of the present invention has the effect of suppressing accumulation of body fat such as visceral fat, and reducing the body weight.
- In the form of known soy products, the content of germ protein is so low that the above-described effects achieved by the present invention cannot be obtained. However, physiological action can be provided by increasing the concentration of the germ protein according to the present invention. More specifically, the effects are achieved by an ingestion of about 0.05 g to 50 g of the soybean germ protein of the present invention per day, so that the protein can be added to various food or beverages.
- The soybean germ protein according to the present invention may be used alone as an active ingredient, or in the form of, for example, a solid, liquid, sol, gel, or plastic composition containing a cereal powder such as starch, oils and fats, emulsifying agent, fragrant material, or thickener according to the requirements of the end product (e.g., drug, functional food, dietary supplement, food, or drink).
- Examples of the starch include corn starch, waxy corn starch, high amylose corn starch, potato starch, wheat starch, tapioca starch, green bean starch, sago starch, rice starch, pea starch, and processed products of these starches prepared by subjecting a starch to single or combined physical or chemical treatment such as esterification treatment, etherification treatment, crosslinking treatment, acid treatment, oxidation treatment, heat-moisture treatment, and gelatinization treatment.
- Examples of the oils and fats include soy oil, soybean germ oil, rapeseed oil, high oleic rapeseed oil, corn oil, sesame oil, sesame salad oil, perilla oil, linseed oil, peanut oil, safflower oil, high oleic safflower oil, sunflower oil, high oleic sunflower oil, high linolic sunflower oil, mid oleic sunflower oil, cottonseed oil, grape seed oil, macadamia nut oil, hazelnut oil, walnut oil, pumpkin seed oil, camellia oil, tea seed oil, olive oil, rice bran oil, wheat germ oil, palm oil, palm olein, palm kernel oil, coconut oil, cacao butter, algae oil, and hydrogenated oil, interesterified oil, and fractionated oil of these oils. These oils may be used alone or in combination of two or more of them.
- The emulsifying agent may be one commonly used for food. Examples of the emulsifying agent include glycerin fatty acid ester, glycerin organic acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, polyglycerin fatty acid ester, polyglycerin-condensed ricinolate, sucrose fatty acid ester, calcium stearoyl lactate, alkyl glycosides, erythritol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, lecithin, enzymatically decomposed lecithin, and enzymatically modified lecithin. These emulsifying agents may be used alone or in combination of two or more of them.
- The fragrant material may be a natural or synthetic fragrant material commonly used in foods.
- The thickener increases the viscosity of the aqueous solution, and examples thereof include polysaccharides such as gum arabic, arabino galactan, guar gum, xanthan gum, psyllium seed gum, gellan gum, Tara gum, locust bean gum, tamarind seed gum, water-soluble soy polysaccharide (hemicellulose), sodium alginate, pullulan, pectin, karaya gum, ghatti gum, gum tragacanth, curdlan, glucomannan, chitin, chitosan, microfibrillar cellulose, and microcrystalline cellulose.
- Examples of other additives include protein-derived substances such as collagen peptide, lactoprotein peptide, casein peptide, oligopeptide, whey protein concentrate, pea protein and gelatin, fibers such as soy fiber and pea fiber, and dextrin such as highly branched cyclic dextrin.
- In addition, a pH adjuster and a saccharide may be added to the soybean germ protein.
- Examples of the pH adjuster include lactic acid, gluconic acid, succinic acid, fumaric acid, citric acid, L-malic acid, DL-malic acid, glacial acetic acid, glucono delta lactone, L-tartaric acid, and DL-tartaric acid.
- Examples of the saccharide include glucose (grape sugar), maltose, fructose (fruit sugar), galactose, trehalose, oligosaccharide, sucrose, and sorbit.
- When the soybean germ protein of the present invention is contained in a baked confectionery such as cookie with a content of 1 to 50%, the baked confectionery has crispness which cannot be achieved with a common soybean protein, and gives a good smell and a good flavor.
- The soybean germ protein of the present invention complements the flavor of food when it is mixed with a grain such as barley, wheat, rice, Japanese millet, foxtail millet, brown rice, black bean, red rice, green rice, red bean, black bean, red kidney bean, chickpea, white kidney bean, or the germ portion of these beans, or a seed such as peanut, walnut, sesame, pine nut, or chestnut. In addition, the soybean germ protein is suitable for, for example, cereals, baked confectionery, and energy bars owing to its physiological functionality.
- The present invention is described in detail with reference to the following examples, but the scope of the present invention is not limited to the examples.
- Soybeans were mechanically crushed, and sieved to obtain a concentrated fraction of soybean germ protein containing 70% or more of soybean germ. The concentrated fraction obtained by the method was subjected to total nitrogen analysis, and confirmed to have a total protein content of 40%. 70% or more of the protein was derived from soybean germ, so that the content of the soybean germ protein in the product was 28% or more, and the concentration factor was 35-fold or more. The protein composition of the sample was analyzed by SDS-PAGE. In the SDS-PAGE analysis, 1 g of the obtained sample was suspended in 5 ml of a 10 mM phosphate buffered saline (PBS: 8.2 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 3 mM KCl), and subjected to ultrasonic treatment for 30 minutes to conduct extraction. 50 μl of the extract was dissolved in 250 μl of 50 mM Tris-HCl buffer containing 35 mM sodium dodecyl sulfate and 1% β-mercaptoethanol, and filtered through a MILLEX-HV 0.22 μm disposable filter to obtain a soluble protein sample. The sample was mixed with 20 μl of a 10% glycerol solution containing 1% bromophenol blue, and subjected to boiling treatment for 5 minutes in a boiling water bath to obtain a sample for electrophoresis. In the above treatment, the addition of β-mercaptoethanol is an important step, because the electrophoretic patterns markedly differ according to whether β-mercaptoethanol is added or not.
- Electrophoresis was carried out using PhastSystem (Pharmacia LKB Biotechnology). The electrophoresis gel was PhastGel, Gradient 10-15, and staining was carried out with CBB. After the electrophoresis, the stained polypeptide bands isolated by SDS-PAGE were analyzed with a chromatoscanner CS9300 (manufactured by Shimadzu Corporation) thereby measuring the absorption at 560 nm. Ordinary soybeans show a strong band in the vicinity of 33 kD, while the soybean germ protein shows a strong band in the vicinity of 30 kD. Similarly, ordinary soybeans show a strong band in the vicinity of 48 kD, while the soybean germ protein shows a characteristic strong band in the vicinity of 52 kD, and shows bands in the vicinity of 21 kD and 35 kD, which are not shown by the ordinary soybean protein. The image was graphed by the chromatoscanner, and the peak areas in the graph indicated that the bands of the soybean germ protein were stronger than those of the ordinary soybean protein.
- The electrophoretic patterns of the proteins are shown in
FIG. 1 . - Soybeans were mechanically crushed, and sieved to obtain a fraction containing 70% or more of soybean germ. The fraction was defatted through hexane extraction at low and high temperatures, which is a common procedure for an oil pressing process, to obtain a soybean germ protein fraction. The soybean germ protein obtained by the above method was subjected to total nitrogen analysis, and found to have a total protein content of 43%, a soybean germ protein content of 30% or more, and a concentration factor of 37-fold or more. The protein composition of the sample was analyzed by SDS-PAGE. In the SDS-PAGE analysis, 1 mg of the obtained sample was suspended in 5 ml of a 10 mM phosphate buffered saline (PBS: 8.2 mM Na2HPO4, 1.8 mM KH2PO4, 137 mMNaCl, 3 mM KCl), and subjected to ultrasonic treatment for 30 minutes to conduct extraction. 50 μl of the extract was dissolved in 250 μl of 50 mM Tris-HCl buffer containing 35 mM sodium dodecyl sulfate and 1% β-mercaptoethanol, and filtered through a MILLEX-HV 0.22 μm disposable filter to obtain a soluble protein sample. The sample was mixed with 20 μl of a 10% glycerol solution containing 1% bromophenol blue, and subjected to boiling treatment for 5 minutes in a boiling water bath to obtain a sample for electrophoresis.
- Electrophoresis was carried out using PhastSystem (Pharmacia LKB Biotechnology). The electrophoresis gel was PhastGel, Gradient 10-15, and staining was carried out with CBB. After the electrophoresis, the stained polypeptide bands isolated by SDS-PAGE were analyzed with a chromatoscanner CS9300 (manufactured by Shimadzu Corporation) thereby measuring the absorption at 560 nm. Ordinary soybeans show a strong band in the vicinity of 33 kD, while the soybean germ protein shows a strong band in the vicinity of 30 kD. Similarly, ordinary soybeans show a strong band in the vicinity of 48 kD, while the soybean germ protein shows a characteristic strong band in the vicinity of 52 kD, and show bands in the vicinity of 21 kD and 35 kD, which are not shown by the ordinary soybean protein. The image was graphed by the chromatoscanner, and the peak areas in the graph indicated that the bands of the soybean germ protein were stronger than those of the ordinary soybean protein.
- The electrophoretic patterns of the defatted proteins are shown in
FIG. 2 . - Soybeans were mechanically crushed, and sieved to obtain a fraction containing 90% or more of soybean germ. The fraction was subjected to hexane extraction in a common procedure for an oil pressing process. Subsequently, 70% hydrous ethanol was added to the fraction, the mixture was stirred at 70° C. for 30 minutes, and then filtered to collect the residue. The residue was subjected to heat treatment at 100° C. for 40 minutes under reduced pressure to obtain a soybean germ protein fraction. The soybean germ protein obtained by the method was subjected to total nitrogen analysis, and found to have a total protein content of 62%, a soybean germ protein content of 56% or more, and a concentration factor of 70-fold or more. The sample was analyzed by SDS-PAGE in the same manner as Test Example 1, and found to have a characteristic composition of soybean germ protein in which the band in the vicinity of 30 kD was stronger than that in the vicinity of 33 kD, the band in the vicinity of 52 kD was stronger than that in the vicinity of 48 kD, and other bands were shown in the vicinity of 21 kD and 35 kD.
- Further, antigenicity to bovine antiserum which was obtained using soybean protein as an antigen was measured by ELISA, and found to be 40 U/10 mg or less. The isoflavone content and saponin content were 0.5% or less, which are one-fifth or less of those in an ordinary soybean germ, and lower than those in whole soybeans. Therefore, high intake of the soybean germ protein will not cause bitterness or a problem of excess intake of these trace components.
FIG. 3 shows an electrophoretic pattern of the concentrated soybean germ protein. - The isoflavone and saponin contents in the soybean germ proteins obtained in Test Examples 1 to 3 were measured.
- Isoflavone content was analyzed according to a method based on the soy isoflavone food standard established by Japan Health Food & Nutrition Food Association, and the isoflavone content was determined in terms of aglycon.
- The saponin content was analyzed by the following method. A sample containing about 10 mg of soy saponin was weighed, and refluxed at 80° C. for 2 hours in 5 ml of a 10% hydrogen chloride-methanol test solution. Insoluble matter was removed from the solution by centrifugation and filtration, and then the solution was analyzed by HPLC. As standard substances for quantitation, 10 mg each of soyasapogenol A and soyasapogenol B manufactured by Koshiro Company Limited were dissolved respectively in 100 ml of ethanol, and the solutions were used. HPLC used ODS columns, and the absorption at UV 210 nm was measured under the conditions of
- mobile phase: acetonitrile/water/methanol (6:3:1);
flow rate: 0.7 ml/min; and temperature: 45° C. The integrated value of the sample was compared with that of the standard substances, and the saponin content was determined in terms of aglycon. The results are shown in Table 1. -
TABLE 1 Isoflavone and saponin contents in soybean germ protein Protein Isoflavone Saponin content content content Test Example 1 40.0% 1.8% 1.7% Test Example 2 43.2% 2.2% 2.1% Test Example 3 62.2% 0.18% 0.33% - High fat diets were fed to rats. The concentrations of various physiological substances in the blood were compared among rats fed with casein, with soybean protein concentrate (hereinafter abbreviated as SPC) as other common soybean protein or with the soybean germ protein of Test Example 3 (hereinafter abbreviated as germ protein).
- Three diets prepared were: 1. casein diet, 2. SPC diet and 3. germ protein diet. The compositions of these diets are summarized in Table 1.
- The germ protein was in the form of powder.
- CD (SD) IGS male rats aged nine weeks were placed in individual cages, and preliminarily bred with a purified diet (AIN93G) for one week. Before starting the main test, the rats were grouped into three divisions each containing eight rats such that the divisions have an equal average body weight. The rats of the respective divisions were fed with 1. casein diet (control), 2. SPC diet containing SPC in place of casein, or 3. germ protein diet containing germ protein in place of casein. The test period was 28 days, and water and the diets were freely ingested. The test was carried out in an animal room under the following conditions: temperature, 22±3° C.; humidity, 60±15%; frequency of ventilation, 12 to 15 times/hour; and photoperiod, 12 hours (7 to 19 o'clock).
- The rats were fasted for 18 hours from the evening of the last day of administration, and the blood was collected from the aorta abdominal is under ether anesthesia. The blood was taken in blood-collecting vessels containing a serum separating medium, and the vessels were centrifuged at 3000 rpm for 15 minutes to separate the serum. The serum was assayed for the levels of LDL cholesterol (
FIG. 4 ), HDL cholesterol (FIG. 5 ), triglyceride (FIG. 7 ), and blood sugar level (FIG. 8 ). Further, the HDL cholesterol/LDL cholesterol ratio was calculated from the LDL cholesterol and HDL cholesterol levels (FIG. 6 ). After blood collection, the rats were exsanguinated to death, their livers were harvested and weighed. Further, mesenteric fat, retroperitoneal fat, perinephric fat and epididymal fat were isolated from the rats of the casein diet group and germ protein diet group to study the accumulation of fats. The measurement values were expressed by average ±standard deviation. In the statistical analysis, Tukey multiple comparison test was carried out as necessary, and the significant differences between the measurement values were examined. -
TABLE 2 Composition of rat diets (unit: %) Ingredients Casein diet SPC diet Germ protein diet Casein 20.0000 — — SPC — 25.6716 — Germ protein — — 28.1967 L-cystine 0.30 0.30 0.30 Lard 35 35 35 Corn starch 19.9486 14.2770 11.7519 Sucrose 15 15 15 Cellulose powder 5 5 5 AIN-93G mineral mixture 3.50 3.50 3.50 AIN-93G vitamin mixture 1.00 1.00 1.00 Choline bitartrate 0.25 0.25 0.25 Tertiary butyl 0.0014 0.0014 0.0014 hydroquinone -
FIGS. 1 to 11 indicate the followings. - 1.
FIG. 4 indicates that the germ protein diet decreases the total blood cholesterol. - 2.
FIG. 5 indicates that the germ protein diet decreases the blood LDL cholesterol. - 3.
FIG. 6 indicates that the germ protein diet increases the blood HDL cholesterol. - 4.
FIG. 7 indicates that the germ protein diet increases the blood HDL/LDL cholesterol ratio more than the casein diet, and that the germ protein diet significantly increased the HDL/LDL ratio in comparison with the SPC diet (P<0.05). The germ protein diet also significantly increased the cholesterol ratio in terms of HDL/total cholesterol in comparison with the SPC diet. - 5.
FIG. 8 indicates that the SPC and germ protein diets significantly decreased the blood triglyceride in comparison with the casein diet (P<0.05). - 6.
FIG. 9 indicates that the SPC and germ protein diets significantly decreased the blood sugar level in comparison with the casein diet (P<0.01 and P<0.05 for the SPC and germ protein diets, respectively). - 7.
FIG. 10 indicates that only the germ protein diet significantly decreased the liver weight per body weight in comparison with the casein diet (P<0.05), which demonstrates that the germ protein diet is effective in prevention of fatty liver. - 8.
FIG. 11 indicates that the accumulation of the mesenteric fat, retroperitoneal fat, perinephric fat and epididymal fat was smaller in weight in the division fed with the germ protein diet than the division fed with the casein diet, which shows that the germ protein diet suppresses accumulation of fats. - The above facts indicate that the germ protein diet decreased the blood triglyceride and blood sugar level in comparison with the casein diet. In addition, the germ protein diet improved the HDL/LDL cholesterol ratio and HDL/total cholesterol ratio in comparison with SPC, showing that it prevents lipid accumulation in the liver. Accordingly, it was proved that the germ protein of the present invention has physiological function different from that of ordinary soybean protein.
- Baked confectionery was made using the soybean germ proteins of Test Examples 1, 2, and 3 as soybean protein materials. As a comparative example, commercial separated soybean protein was used in place of the soybean germ proteins. The ingredients are as follows.
-
Weak flour 130 g Butter 100 g Soybean protein material 100 g Sugar 80 g Egg 1 Vanilla essence few drops - An appropriate amount of milk was added to and mixed with the above ingredients. The dough was preserved at 4° C. for 2 hours, shaped into disks having a diameter of about 3 cm, and baked in an oven at 170° C. for about 12 minutes to make cookies. The cookies were tasted, and evaluated by sensory test by ten panelists. As a result of the sensory test, the cookies made of the soybean germ protein were more fragrant and crisp than those made of the separated soybean protein, and thus achieved higher scores in terms of flavor, texture, and taste.
-
TABLE 3 Result of sensory test (fractional components are rounded off) Fragrance Crispness Taste Test Examples 1 3 4 3 Test Examples 2 4 5 4 Test Examples 3 5 5 5 Comparative Example 2 2 1 5: very good; 4: good; 3: normal; 2: not good; 1: bad
Claims (19)
1. A composition for improving metabolic syndrome, comprising soybean germ protein as an active ingredient.
2. The composition according to claim 1 , wherein metabolic syndrome is improved through improvement of lipid metabolism.
3. The composition according to claim 1 , wherein lipid metabolism is improved through improvement of HDL/LDL cholesterol ratio and/or reduction of blood triglyceride level.
4. The composition according to claim 1 , wherein metabolic syndrome is improved through reduction of blood sugar level and/or control of increase the liver weight.
5. A composition for reducing body weight, comprising soybean germ protein as an active ingredient.
6. The composition according to claim 1 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
7. An agent for improving blood HDL/LDL cholesterol ratio, reducing blood triglyceride level, reducing blood sugar level, and/or reducing body weight, the agent comprising soybean germ protein as an active ingredient.
8. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 1 .
9. The composition according to claim 2 , wherein lipid metabolism is improved through improvement of HDL/LDL cholesterol ratio and/or reduction of blood triglyceride level.
10. The composition according to claim 2 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
11. The composition according to claim 3 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
12. The composition according to claim 9 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
13. The composition according to claim 4 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
14. The composition according to claim 5 , wherein the soybean germ protein is a substance obtained by treating soybean germ through a process including solvent treatment and heat treatment.
15. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 2 .
16. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 3 .
17. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 9 .
18. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 4 .
19. Foods, beverages, functional foods, dietary supplements, and diets comprising the composition according to claim 5 .
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006208949A JP3944864B1 (en) | 2006-07-31 | 2006-07-31 | Composition for prevention and improvement of metabolic syndrome |
JP2006-208949 | 2006-07-31 | ||
PCT/JP2007/062333 WO2008015850A1 (en) | 2006-07-31 | 2007-06-19 | Composition for prevention and amelioration of metabolic syndrome |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/062333 A-371-Of-International WO2008015850A1 (en) | 2006-07-31 | 2007-06-19 | Composition for prevention and amelioration of metabolic syndrome |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/652,748 Division US8586529B2 (en) | 2006-07-31 | 2012-10-16 | Composition for preventing and improving metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090186145A1 true US20090186145A1 (en) | 2009-07-23 |
Family
ID=38344671
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/227,951 Abandoned US20090186145A1 (en) | 2006-07-31 | 2007-06-19 | Composition for Preventing and Improving Metabolic Syndrome |
US13/652,748 Expired - Fee Related US8586529B2 (en) | 2006-07-31 | 2012-10-16 | Composition for preventing and improving metabolic syndrome |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/652,748 Expired - Fee Related US8586529B2 (en) | 2006-07-31 | 2012-10-16 | Composition for preventing and improving metabolic syndrome |
Country Status (4)
Country | Link |
---|---|
US (2) | US20090186145A1 (en) |
JP (1) | JP3944864B1 (en) |
CN (2) | CN101448511A (en) |
WO (1) | WO2008015850A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190224260A1 (en) * | 2016-07-13 | 2019-07-25 | J-Oil Mills, Inc. | Metabolic Syndrome Inhibitor |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5504441B2 (en) * | 2009-03-25 | 2014-05-28 | 株式会社J−オイルミルズ | Mitochondrial fusion promoter |
JP5106468B2 (en) * | 2009-04-16 | 2012-12-26 | 日本製粉株式会社 | Low calorie jerky-like snack for dogs and method for producing the same |
US9839644B2 (en) | 2014-09-09 | 2017-12-12 | ARKAY Therapeutics, LLC | Formulations and methods for treatment of metabolic syndrome |
CN116650548A (en) * | 2023-05-25 | 2023-08-29 | 无锡益和普食品产业发展有限公司 | Application of Whole Soybean Milk in Improving Lipid Metabolism |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3653912A (en) * | 1969-12-22 | 1972-04-04 | Gen Mills Inc | Preparation and use of a bland dispersible food protein |
US5792852A (en) * | 1992-11-16 | 1998-08-11 | Cancer Research Fund Of Contra Costa | Polynucleotides encoding modified antibodies with human milk fat globule specificity |
US20010026814A1 (en) * | 1999-04-23 | 2001-10-04 | Protein Technologies International, Inc. | Composition for and method of reducing low density lipoprotein cholesterol concentration |
US20030139610A1 (en) * | 2001-07-24 | 2003-07-24 | Khare Anil Bhagwan | Process for isolating phenolic compounds |
US20040013791A1 (en) * | 2002-05-07 | 2004-01-22 | Navpreet Singh | Low isoflavones, high saponins soy protein product and process for producing the same |
US20040071800A1 (en) * | 1999-04-23 | 2004-04-15 | The Solae Company, Llc. | Method of reducing low density lipoprotein cholesterol concentration |
US20040146627A1 (en) * | 2000-11-09 | 2004-07-29 | Beaver Michael J. | Soybean processing |
US20050129832A1 (en) * | 2003-12-12 | 2005-06-16 | Hammond Roger C. | Bean germ extracts |
US20070003642A1 (en) * | 2002-12-24 | 2007-01-04 | Satoshi Wanezaki | Composition containing high concentration of isoflavone and having high solubility and process for producing the same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003088334A (en) | 1999-03-31 | 2003-03-25 | Fuji Oil Co Ltd | Composition for reducing cholesterol in blood |
EP1491192A4 (en) | 2002-03-15 | 2007-08-15 | Nichimo Kk | Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
JP2003286180A (en) * | 2002-03-28 | 2003-10-07 | Fuji Oil Co Ltd | Obesity inhibitor and food containing the same |
CN1662142A (en) * | 2002-04-18 | 2005-08-31 | 孟山都技术有限公司 | Oil body associated protein compositions, methods of and use thereof for reducing the risk of cardiovascular disease |
AU2003278602C1 (en) * | 2002-06-20 | 2010-08-12 | Pronova Biopharma Norge As | Sulfur-containing phospholipid derivatives |
JP2005023756A (en) * | 2003-07-04 | 2005-01-27 | Ikeda Kenzai Kogyo Kk | Backing paper sewn on lath |
JP2005237356A (en) | 2004-02-25 | 2005-09-08 | Kato Seiyu Kk | Super finely powdered, dehulled, defatted soybean powder and method for producing defatted soybean germ powder-processed food |
JP4482885B2 (en) * | 2005-02-14 | 2010-06-16 | 株式会社J−オイルミルズ | Soy germ protein composition |
US20090186347A1 (en) * | 2007-05-11 | 2009-07-23 | Cox David R | Markers for metabolic syndrome |
US8173178B1 (en) * | 2007-08-03 | 2012-05-08 | Decas Botanical Synergies, Llc | Compositions and methods for controlling metabolic syndrome using whole fruit-derived cranberry ingredient profile enriched in stress adapted bioactives (SABs) |
WO2009141352A2 (en) * | 2008-05-20 | 2009-11-26 | F. Hoffmann-La Roche Ag | Risk analysis in patients with and without metabolic syndrome |
EP2368552A1 (en) * | 2010-03-25 | 2011-09-28 | Boehringer Ingelheim Vetmedica GmbH | 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
WO2012024638A2 (en) * | 2010-08-20 | 2012-02-23 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
-
2006
- 2006-07-31 JP JP2006208949A patent/JP3944864B1/en active Active
-
2007
- 2007-06-19 WO PCT/JP2007/062333 patent/WO2008015850A1/en active Application Filing
- 2007-06-19 US US12/227,951 patent/US20090186145A1/en not_active Abandoned
- 2007-06-19 CN CNA2007800179240A patent/CN101448511A/en active Pending
- 2007-06-19 CN CN2012105042660A patent/CN103005462A/en active Pending
-
2012
- 2012-10-16 US US13/652,748 patent/US8586529B2/en not_active Expired - Fee Related
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3653912A (en) * | 1969-12-22 | 1972-04-04 | Gen Mills Inc | Preparation and use of a bland dispersible food protein |
US5792852A (en) * | 1992-11-16 | 1998-08-11 | Cancer Research Fund Of Contra Costa | Polynucleotides encoding modified antibodies with human milk fat globule specificity |
US20010026814A1 (en) * | 1999-04-23 | 2001-10-04 | Protein Technologies International, Inc. | Composition for and method of reducing low density lipoprotein cholesterol concentration |
US20010029248A1 (en) * | 1999-04-23 | 2001-10-11 | Protein Technologies International, Inc. | Composition for and method of reducing low density lipoprotein cholesterol concentration |
US6544566B1 (en) * | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
US20040071800A1 (en) * | 1999-04-23 | 2004-04-15 | The Solae Company, Llc. | Method of reducing low density lipoprotein cholesterol concentration |
US20040146627A1 (en) * | 2000-11-09 | 2004-07-29 | Beaver Michael J. | Soybean processing |
US20030139610A1 (en) * | 2001-07-24 | 2003-07-24 | Khare Anil Bhagwan | Process for isolating phenolic compounds |
US20040013791A1 (en) * | 2002-05-07 | 2004-01-22 | Navpreet Singh | Low isoflavones, high saponins soy protein product and process for producing the same |
US20070003642A1 (en) * | 2002-12-24 | 2007-01-04 | Satoshi Wanezaki | Composition containing high concentration of isoflavone and having high solubility and process for producing the same |
US7560131B2 (en) * | 2002-12-24 | 2009-07-14 | Fuji Oil Company, Limited | High solubility composition with high isoflavone concentration and process of producing same |
US20050129832A1 (en) * | 2003-12-12 | 2005-06-16 | Hammond Roger C. | Bean germ extracts |
Non-Patent Citations (1)
Title |
---|
Hu et al. (2002) Quantification of the Group B Soyasaponins by High-Performance Liquid Chromatography. J. Agric. Food chem., Vol. 50, No.9, pages 2587-2594. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190224260A1 (en) * | 2016-07-13 | 2019-07-25 | J-Oil Mills, Inc. | Metabolic Syndrome Inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN101448511A (en) | 2009-06-03 |
US8586529B2 (en) | 2013-11-19 |
JP3944864B1 (en) | 2007-07-18 |
WO2008015850A1 (en) | 2008-02-07 |
JP2008031121A (en) | 2008-02-14 |
US20130065821A1 (en) | 2013-03-14 |
CN103005462A (en) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saucedo-Pompa et al. | Moringa plants: Bioactive compounds and promising applications in food products | |
Goyal et al. | Flax and flaxseed oil: an ancient medicine & modern functional food | |
Christa et al. | Buckwheat grains and buckwheat products–nutritional and prophylactic value of their components–a review | |
DE202009018158U1 (en) | Chia seed composition | |
US8586529B2 (en) | Composition for preventing and improving metabolic syndrome | |
Martín-Cabrejas | Legumes: an overview | |
US9011841B2 (en) | Flour-based functional food | |
JPH11187843A (en) | Food and beverage composition for improving obesity and food and beverage containing the same | |
Manzoor et al. | Rice bran: Nutritional, phytochemical, and pharmacological profile and its contribution to human health promotion | |
Bhathal et al. | Quinoa-a treasure trove of nutrients | |
KR101913347B1 (en) | The sauce using fermented ginger soybean and method for preparation thereof | |
RU2352146C2 (en) | Composition (versions) and oat food product | |
Nissen et al. | Industrial hemp foods and beverages and product properties | |
JP2015198586A (en) | Green juice food product, and method for producing the same | |
KR101622767B1 (en) | Method for Manufacturing Sauce for spiced rib Using dietary Fiber | |
Shevkani | Protein from land—legumes and pulses | |
Kumar et al. | Radha; Dhumal, S.; Singh, S.; et al. Valorization Potential of Tomato (Solanum lycopersicum L.) Seed: Nutraceutical Quality, Food Properties, Safety Aspects, and Application as a Health-Promoting Ingredient in Foods | |
Edo et al. | A review on the biological and bioactive components of Cyperus esculentus L.: insight on food, health and nutrition | |
Singh et al. | Amazing health benefit of fenugreek (Trigonella foenumgraecum Linn.) | |
KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
KR101200584B1 (en) | Manufacturing method of a fermented sugar-soak blackbean snacks | |
Vernaza et al. | Brazilian soybean products: functional properties and bioactive compounds | |
ManzOOri | Pigmented Pseudocereals: Chemistry, Functionality, and Technological Aspects in Food Systems | |
Sowdhanya et al. | Nutritional significance of velvet bean (Mucuna pruriens) and opportunities for its processing into value-added products | |
Mehany et al. | Pigmented Pseudocereals: Chemistry, Functionality, and Technological Aspects in Food Systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: J-OIL MILLS, INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SAITO, SANSHIROU;SATO, TOSHIRO;ISOBE, YOUSUKE;AND OTHERS;REEL/FRAME:021959/0242 Effective date: 20081128 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |